"SciGen Announces Launch of Sci-B-Vac in Hong Kong"
Australian Associated Press (05/15/03) (aap.com.au)
SciGen has launched a new hepatitis B vaccine, called Sci-B-Vac, in Hong
Kong. The vaccine is already available in several Asia-Pacific nations,
and the company has also submitted it for approval in Australia, New
Zealand, and India. The hepatitis B rate in Hong Kong is estimated at
between 8 percent and 10 percent.